Diepoxybutane induces caspase and p53-mediated apoptosis in human lymphoblasts

Toxicology and Applied Pharmacology

Volumn 195, Issue 2, 2004, Pages 154-165

  Yadavilli, Sridevi ^a   Muganda, Perpetua M ^a  

^a SOUTHERN UNIVERSITY   (United States)

Author keywords

Apoptosis; Butadiene; Caspase 3; Caspase 9; Diepoxybutane; Human lymphoblasts; Human lymphocytes; NH32; P53; TK6

Indexed keywords

BUTADIENE DIEPOXIDE; CASPASE; CASPASE 3; CASPASE 9; PROTEIN P53;

APOPTOSIS; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOBLAST; PETROCHEMICAL INDUSTRY;

APOPTOSIS; B-LYMPHOCYTES; CASPASE 3; CASPASE 9; CASPASES; CELL DIVISION; CELL LINE; CELL SURVIVAL; ENZYME ACTIVATION; EPOXY COMPOUNDS; HUMANS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 1442348470     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.11.006     Document Type: Conference Paper

References (59)

1. Abdel-Rahman S.Z., El-Zein R.A., Ammenheuser M.M., Yang Z., Stock T.H., Morandi M., Ward J.B. Jr. Variability in human sensitivity to 1,3-butadiene: influence of the allelic variants of the microsomal epoxide hydrolase gene. Environ. Mol. Mutagen. 41:2003;140-146.
2. Agrawal S., Agarwal M.L., Chatterjee-Kishore M., Stark G.R., Chisolm G. Stat1-dependent, p53-independent expression of p21 modulates oxysterol-induced apoptosis. Mol. Cell. Biol. 22:2002;1981-1992.
3. Albertini R., Clewell H., Himmelstein M.W., Morinello E., Olin S., Preston J., Scarano L., Smith M.T., Swenberg J.A., Tice R., Travis C. The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene. Regul. Toxicol. Pharmacol. 37:2003;105-132.
4. Ammenheuser M.M., Bechtold W.E., Abdel-Rahman S.Z., Rosenblatt J.I., Hastings-Smith D.A., Ward J.B. Jr. Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker. Environ. Health Perspect. 109:2001;1249-1255.
5. Bond J.A., Medinsky M.A. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene. Chem.-Biol. Interact. 135-136:2001;599-614.
6. Bratton S.B., Cohen G.M. Apoptotic death sensor: an organelle's alter ego? Trends Pharmacol. Sci. 22:2001;306-315.
7. Checkoway H., Williams T.M. A hematology survey of workers at a styrene-butadiene synthetic rubber manufacturing plant. Am. Ind. Hyg. Assoc. J. 43:1982;164-169.
8. Ching J.C.Y., Jones N.L., Ceponis P.J.M., Karmali M.A., Sherman P.M. Escherichia coli shiga-like toxins induce apoptosis and cleavage of Poly (ADP-Ribose) polymerase via in vitro activation of caspases. Infect. Immun. 70:2002;4669-4677.
9. Coelho D., Fischer B., Holl V., Jung G.M., Dufour P., Bergerat J.P., Denis J.M., Gueulette J., Bischoff P. Involvement of TP53 in apoptosis induced in human lymphoblastoid cells by fast neutrons. Radiat. Res. 157:2002;446-452.
10. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
11. Creagh E.M., Martin S.J. Caspases: cellular demolition experts. Biochem. Soc. Trans. 29:2001;696-701.
12. Doerr J.K., Hollis E.A., Sipes I.G. Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats. Toxicology. 113:1996;128-136.
13. Duke R.C., Cohen J.J. Morphological and biochemical assays of apoptosis. Curr. Prot. Immunol. 1992;. (1:3.17.1-3.17.16).
14. Erexson G.L., Tindall K.R. Micronuclei and gene mutations in transgenic Big Blue(R) mouse and rat fibroblasts after exposure to the epoxide metabolites of 1,3-butadiene. Mutat. Res. 472:2000;105-117.
15. Erexson G.L., Tindall K.R. Reduction of diepoxybutane-induced sister chromatid exchanges by glutathione peroxidase and erythrocytes in transgenic Big Blue mouse and rat fibroblasts. Mutat. Res. 447:2000;267-274.
16. Geske F.J., Gerschenson L.E. The biology of apoptosis. Hum. Pathol. 32:2001;1029-1038.
17. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int. J. Oncol. 22:2003;15-20.
18. Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis - The p53 network. J. Cell Sci. 116:2003;4077-4085.
19. Haupt S., Louria-Hayon I., Haupt Y. p53 licensed to kill? Operating the assassin. J. Cell. Biochem. 88:2003;76-82.
20. Hong H.H., Devereux T.R., Melnick R.L., Moomaw C.R., Boorman G.A., Sills R.C. Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol. Pathol. 28:2000;529-534.
21. Hughes K., Meek M.E., Walker M., Beauchamp R. 1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis. J. Toxicol. Environ. Health, Part B. Crit. Rev. 6:2003;55-83.
22. IARC Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. IARC Monogr. Eval. Carcinog. Risk Hum. 71:1999;109-225.
23. IARC., 1999b. 1,3-Butadiene; chloroprene; isoprene. IARC Monogr Eval Carcinog Risks Hum, Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide, vol. 71, 109-225, 227-250, 1015-1025.
24. Irons R.D., Pyatt D.W., Stillman W.S., Som D.B., Claffey D.J., Ruth J.A. Comparative toxicity of known and putative metabolites of 1,3-butadiene in human CD34(+) bone marrow cells. Toxicology. 150:2000;99-106.
25. Ishida R., Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. Cancer Res. 42:1982;4000-4006.
26. Jackson M.A., Stack H.F., Rice J.M., Waters M.D. A review of the genetic and related effects of 1,3-butadiene in rodents and humans. Mutat. Res. 463:2000;181-213.
27. Landi S., Norppa H., Frenzilli G., Cipollini G., Ponzanelli I., Barale R., Hirvonen A. Individual sensitivity to cytogenetic effects of 1,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics. 8:1998;461-471.
28. Leger C., Drobetsky E.A. Modulation of the DNA damage response in UV-exposed human lymphoblastoid cells through genetic- versus functional-inactivation of the p53 tumor suppressor. Carcinogenesis. 23:2002;1631-1639.
29. Lin Y.S., Smith T.J., Kelsey K.T., Wypij D. Human physiologic factors in respiratory uptake of 1,3-butadiene. Environ. Health Perspect. 109:2001;921-926.
30. Loo D.T., Rillema J.R. Measurement of cell death. Methods Cell Biol. 57:1998;251-264.
31. McGahon A.J., Martin S.J., Bissonnette R.P., Mahboubi A., Shi Y., Mogil R.J., Nishioka W.K., Green D.R. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol. 46:1995;153-185.
32. Medinsky M.A., Leavens T.L., Csanady G.A., Gargas M.L., Bond J.A. In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. Carcinogenesis. 15:1994;1329-1340.
33. Melnick R.L., Huff J.E. 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8000 parts per million. IARC Sci. Publ. 127:1993;309-322.
34. Melnick R.L., Sills R.C. Comparative carcinogenicity of 1,3-butadiene, isoprene, and chloroprene in rats and mice. Chem. Biol. Int. 135-136:2001;27-42.
35. Mertens-Talcott S.U., Talcott S.T., Percival S.S. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J. Nutr. 133:2003;2669-2674.
36. Morrow N.L. Significance of 1,3-butadiene to the US air toxics regulatory effort. Chem. Biol. Int. 135-136:2001;137-143.
37. Muganda P., Mendoza O., Hernandez J., Qian Q. Human cytomegalovirus elevates levels of the cellular p53 protein in infected fibroblasts. J. Virol. 68:1994;8028-8034.
38. Murg M., Schuler M., Eastmond D.A. Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes. Mutagenesis. 14:1999;541-546.
39. National Toxicology Program, 1993. NTP toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (Inhalation Studies), National Toxicol. Program Tech. Rep. Ser.1993, 1-389.
40. National Toxicology Program, 2000. 1,3-Butadiene. 9th Report on Carcinogens III-14-III-17.
41. Oren M. Decision making by p53: life, death, cancer. Cell Death Differ. 10:2003;431-442.
42. Porto B., Chiecchio L., Gaspar J., Faber A., Pinho L., Rueff J., Malheiro I. Role of haemoglobin in the protection of cultured lymphocytes against diepoxybutane (DEB), assessed by in vitro induced chromosome breakage. Mutat. Res. 536:2003;61-67.
43. Recio L., Saranko C.J., Steen A.M. 1,3-butadiene: cancer, mutations, and adducts. Part II: roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Res. Rep. Health Effic. Inst. 2000;49-87. (discussion 141-149).
44. Recio L., Steen A.M., Pluta L.J., Meyer K.G., Saranko C.J. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem. Biol. Int. 135-136:2001;325-341.
45. Robertson J.D., Orrenius S. Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit. Rev. Toxicol. 30:2000;609-627.
46. Robles A.I., Harris C.C. p53-Mediated apoptosis and genomic instability diseases. Acta Oncol. 40:2001;696-701.
47. Shen Y., White E. p53-Dependent apoptosis pathways. Adv. Cancer Res. 82:2001;55-84.
48. Sjoblom T., West A., Lahdetie J. Apoptotic response of spermatogenic cells to the germ cell mutagens etoposide, adriamycin, and diepoxybutane. Environ. Mol. Mutagen. 31:1998;133-148.
49. Smith T.J., Lin Y.S., Mezzetti M., Bois F.Y., Kelsey K., Ibrahim J. Genetic and dietary factors affecting human metabolism of 1,3-butadiene. Chem. Biol. Int. 135-136:2001;407-428.
50. Squier M.K., Cohen J.J. Standard quantitative assays for apoptosis. Mol. Biotechnol. 19:2001;305-312.
51. Steele R.J., Thompson A.M., Hall P.A., Lane D.P. The p53 tumour suppressor gene. Br. J. Surg. 85:1998;1460-1467.
52. Steen A.M., Meyer K.G., Recio L. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis. 12:1997;61-67.
53. Stewart Z.A., Pietenpol J.A. p53 Signaling and cell cycle checkpoints. Chem. Res. Toxicol. 14:2001;243-263.
54. Surh C.D., Kishimoto H., Sprent J. Morphological, biochemical and cytometric assays of apoptosis. Coligan J.E. Current Protocols in Immunology. 1997;3.17.1-3.17.3 Wiley, New York, NY.
55. van Gurp M., Festjens N., van Loo G., Saelens X., Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem. Biophys. Res. Commun. 304:2003;487-497.
56. Vousden K.H. Activation of the p53 tumor suppressor protein. Biochim. Biophys. Acta. 1602:2002;47-59.
57. Zhao C., Vodicka P., Sram R.J., Hemminki K. Human DNA adducts of 1,3-butadiene, an important environmental carcinogen. Carcinogenesis. 21:2000;107-111.
58. Zhao C., Vodicka P., Sram R.J., Hemminki K. DNA adducts of 1,3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ. Mol. Mutagen. 37:2001;226-230.
59. Zhuang S.M., Wiseman R.W., Soderkvist P. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice. Oncogene. 21:2002;5643-5648.